文献速递糖尿病

糖尿病中的经济激励、收入补充、现金转移与全民基本收入干预:理解差异与有效性:一项范围综述

Financial Incentives, Income Supplementation, Cash Transfer, and Universal Basic Income Interventions in Diabetes: Understanding Differences and Effectiveness: A Scoping Review.
PubMed 文献 · Diabetes Care · 2025-01-01

本范围综述检索OVID Medline、PubMed、Scopus和CINAHL从建库至2024年7月的文献,最终纳入13篇,评估货币干预对糖尿病结局的影响。13项研究中10项发现HbA1c有统计学显著且具临床意义的改变,纳入研究分别采用经济激励、收入补充、现金转移或其组合。作者认为证据支持货币干预与糖尿病相关结局及自我照护行为之间的关系,未来研究应比较不同货币干预方式并探索其中介机制。

要点

  • 13项纳入研究中,8项采用经济激励、3项采用收入补充、1项采用现金转移、1项采用收入补充联合经济激励。
  • 13项研究中10项报告HbA1c出现统计学显著且具临床意义的改变。
  • 经济激励干预的HbA1c变化范围为0.19%至1.74%,收入补充为0.7%至1.3%,现金转移为0.2%至0.7%。

核心结论

  • 证据总体上支持货币干预方式与糖尿病相关结局及自我照护行为之间的关系。
  • 作者认为未来研究应考虑采用能够识别有效策略的设计来比较不同货币干预方式。
  • 作者认为由于这些方式在理论和结构上不同,亟需识别其变化 underlying 机制的路径。

研究设计与样本

  • 本项范围综述采用可重复的检索策略,检索OVID Medline、PubMed、Scopus和CINAHL,检索时间从建库至2024年7月。
  • 最终纳入13篇文章进行综合合成。
  • 纳入研究的货币干预方式包括经济激励(8项)、收入补充(3项)、现金转移(1项)以及收入补充联合经济激励(1项)。

主要发现

  • 13项研究中10项发现HbA1c出现统计学显著且具临床意义的改变。
  • 接受经济激励干预的参与者HbA1c变化范围为0.19%至1.74%。
  • 接受收入补充干预的参与者HbA1c变化范围为0.7%至1.3%。
  • 采用现金转移的研究中HbA1c变化范围为0.2%至0.7%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The objective of this review is to evaluate and summarize the evidence base for the effects of monetary intervention approaches (the use of positive monetary reinforcers and gains) on diabetes outcomes. A reproducible search using OVID Medline, PubMed, Scopus, and CINAHL was conducted. Articles published from database creation up to July 2024 were searched. Outcomes included hemoglobin A1c (HbA1c), LDL, BMI, blood pressure, quality of life (QOL), psychosocial factors, self-care behaviors, and diabetes complications. A total of 13 articles met inclusion criteria and were included for final synthesis. Looking at the monetary approach across each study, eight used financial incentives, three used a form of income supplementation, one used cash transfers, and one used a combination of income supplementation and financial incentives. Ten of the 13 studies found statistically significant and clinically meaningful changes in HbA1c. For participants receiving interventions, change in HbA1c ranged from 0.19% to 1.74% for interventions incorporating financial incentives, 0.7% to 1.3% for interventions incorporating income supplementation, and 0.2% to 0.7% for the study incorporating cash transfers. Overall, evidence supports the relationship between monetary approaches, diabetes-related outcomes, and self-care behaviors across monetary approaches. Future studies should consider comparison between different monetary approaches using designs that will allow identification of effective strategies. As these approaches are theoretically and structurally different, pathways identifying the underlying mechanisms of change are greatly needed to advance the field.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Egede LE, Campbell JA, Linde S, et al. Financial Incentives, Income Supplementation, Cash Transfer, and Universal Basic Income Interventions in Diabetes: Understanding Differences and Effectiveness: A Scoping Review. Diabetes Care. 2025. PMID: 39808530. doi:10.2337/dci24-0072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。